Results 321 to 330 of about 370,815 (388)

Perigraftitis treatment and histology: A case report

Clinical Advances in Periodontics, EarlyView.
Abstract Background Currently, the two diagnoses of inflammatory peri‐implant diseases are peri‐implant mucositis and peri‐implantitis. The etiology of peri‐implant mucositis and peri‐implantitis is bacterial colonization of the implant. Thus, removal of the implant should eliminate the infection and allow the inflammation to resolve. However, at least
Jonathan H. Do, Charles M. Cobb, John T. Shen   +2 more
wiley   +1 more source

The use of platelet-rich fibrin prepared with titanium tubes (T-PRF) in external maxillary sinus lift combined with simultaneous implant placement (case series). [PDF]

Int J Surg Case Rep
Awad ZI, Beit ZZK.
europepmc   +1 more source

Design and Evaluation of Sticky End‐Type Bivalent DNA Aptamers Containing M08s‐1 as Anticoagulant Agents

ChemMedChem, EarlyView.
Sticky end‐type antithrombin aptamer, composed of two short hybridizable segments, is developed as a potential alternative to conventional anticoagulant drugs. The obtained bivalent aptamer surpasses existing long bivalent aptamers in anticoagulant activity and serum stability, offering advantages in synthesis efficiency and cost‐effectiveness. Aptamer
Maasa Yokomori, Mizuki Murasawa, Muneyuki Matsuo, Masanobu Nagano, Keitaro Yoshimoto   +4 more
wiley   +1 more source

Aesthetic and Functional Outcomes After Superficial Parotidectomy - Comparison of Three Reconstruction Techniques: An Interventional Clinical Study. [PDF]

Int Arch Otorhinolaryngol
Askar SM, Said AE, Oraby T, Khaled I, Megahed MA, Awad AM.   +5 more
europepmc   +1 more source

Quantitative Model‐Informed Dose Selection for a Milvexian Phase III Study in Patients With Atrial Fibrillation

Clinical Pharmacology &Therapeutics, EarlyView.
Milvexian, an activated factor XI inhibitor, is being evaluated in the LIBREXIA phase III program for the prevention of thrombotic events, including in patients with atrial fibrillation (LIBREXIA AF). To guide the selection of a phase III dose regimen for LIBREXIA AF, two main approaches were used: (1) population pharmacokinetics and exposure–response ...
Wangda Zhou, Emily Bozenhardt, Gregory E. Alexander, Matthew L. Zierhut, Samira Merali, Antoinette Ajavon‐Hartmann, Peter Zannikos, Hyunmoon Back, EunYoung Suh, Navin Goyal, Mahesh N. Samtani, Alexei N. Plotnikov, Chandni Valiathan   +12 more
wiley   +1 more source

Implications of the c.1201C > G (p.Arg401Gly) mutation in <i>FGG</i> gene on fibrinogen stability and function. [PDF]

Front Med (Lausanne)
Lu J, Xiang Z, Ye Y, Chen W, Tan J, Kuang B, Liu J.   +6 more
europepmc   +1 more source

Rodent monocyte‐derived macrophages do not express CD163: Comparative analysis using macrophages from living boreoeutherians

Developmental Dynamics, EarlyView.
Abstract Background CD163 is a scavenger receptor predominantly expressed on the surfaces of macrophages in various mammalian species and is a marker of anti‐inflammatory (M2‐like) macrophages. High density of CD163‐positive tumor‐associated macrophages (TAMs) is associated with worse prognosis in various patient tumors.
Yoichi Saito, Yukio Fujiwara, Yasuka L. Yamaguchi, Satomi S. Tanaka, Kyoko Miura, Yoshiyuki Hizukuri, Kyoko Yamashiro, Yasuhiro Hayashi, Yuta Nakashima, Yoshihiro Komohara   +9 more
wiley   +1 more source

Rapid Determination of Xa Inhibitor Activity in Blood Using a Microfluidic Device that Measures Platelet Deposition and Fibrin Generation Under Flow

TH Open
Jason M. Rossi, Karen A. Panckeri, Soumita Ghosh, Tilo Grosser, Adam Cuker, Scott L. Diamond   +5 more
doaj   +1 more source

The Use of Fibrin Clot During Meniscus Repair in Young Patients Reduces Clinical Symptom Rates at 12-Month Follow-Up: A Pilot Randomized Controlled Trial. [PDF]

Medicina (Kaunas)
Martinkėnienė VB, Austys D, Brazaitis A, Makulavičius A, Aukštikalnis T, Dockienė I, Verkauskas G.   +6 more
europepmc   +1 more source

Efficacy of Fibrin Clot Implantation for Reduction of Bone Tunnel Enlargement in Double-Bundle ACL Reconstruction Using Autogenous Hamstring Graft. [PDF]

Orthop J Sports Med
Suzuki N, Onishi S, Kanto R, Nakayama H, Yoshiya S, Tachibana T, Iseki T.   +6 more
europepmc   +1 more source